DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID ▼ | Gene Name | UniProt ID |
---|---|---|---|---|---|
C2937421 | Prostatic Hyperplasia | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0086873 | Pseudopelade | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0028960 | Oligospermia | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0006826 | Malignant Neoplasms | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0266362 | Ambiguous Genitalia | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0476089 | Endometrial Carcinoma | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0033575 | Prostatic Diseases | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0010417 | Cryptorchidism | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0038436 | Post-Traumatic Stress Disorder | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0006142 | Malignant neoplasm of breast | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0008043 | Chiari-Frommel Syndrome | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C4721610 | Carcinoma, Ovarian Epithelial | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0002170 | Alopecia | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C4083212 | Alopecia, Male Pattern | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0027708 | Nephroblastoma | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0345904 | Malignant neoplasm of liver | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0007103 | Malignant neoplasm of endometrium | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0005001 | Benign prostatic hypertrophy | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0238395 | Male Pseudohermaphroditism | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0524620 | Metabolic Syndrome X | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0014170 | Endometrial Neoplasms | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0004509 | Azoospermia | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0269102 | Endometrioma | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0238339 | Hereditary pancreatitis | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | SRD5A2 | 6716 | steroid 5 alpha-reductase 2 | P31213 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024